Webcast Library

 
Webcast Library

Bookmark our Webcast Library for the latest industry webcasts and webinars.

Registration may be required for viewing.

Table of Contents

Webcasts

Pharma’s Green Evolution

Big Pharma has gone green, but smaller manufacturers have yet to flip the switch, say industry experts and our own survey.

Click Here

PharmaView: Trading Places at Biogen, with Real Results

At Biogen Idec, a high-level job swap has proven anything but frivolous for everyone involved.

Click Here

The New Microbiological Technology Wave

In an excerpt from an important new book, Pfizer's Claudio Denoya looks at alternative microbiological methods, and their connection with process analytical technology (PAT).

Click Here

Funny Pharm: You Write the Caption & Win: January 2011

Introducing "Funny Pharm," sponsored by Paratherm Corp., featuring drawings by award-winning cartoonist Jerry King. Submit your caption and win.

Click Here

Onsite and Online, Interphex Attracting Visitors

The annual spring tradeshow has reenergized itself by building a year-round online presence.

Click Here

Building a Modeling Culture in Manufacturing at Pfizer

At Pfizer, the value of models is not in mimicking reality, but in illustrating the interactions between people, equipment, materials, and time.

Click Here

Pharma Jobs 2011: Curb Your Enthusiasm, and Ego

There’s still not enough evidence for full-fledged optimism, says a leading recruiter.

Click Here

Quality Circle: A Primer for Business Performance Management

What has emerged from Pharma's tough journey is a newfound appreciation for business performance.

Click Here

Funny Pharm: You Write the Caption & Win: January 2011

Introducing "Funny Pharm," sponsored by Paratherm Corp., featuring drawings by award-winning cartoonist Jerry King. Submit your caption and win.

Click Here

PharmaView: CEOs: Head Cases?

For CEOs, maybe therapy comes with the territory.

Click Here

Digital Insights: J&J Rivals Tiger Woods & BP in Bad Web Press

Pharma Web Buzz: Johnson & Johnson rivaling Tiger Woods and BP in 2010 bad web press.

Click Here

Process Development and Manufacturing Need To Be One Team

Justin Neway, CSO of Aegis Analytical discusses pharmaceutical process development, QbD, and manufacturing.

Click Here

From the Editor: QbD and the People Space

In addition to the Design Space and the Control Space, should the “People Space” be added to the QbD lexicon?

Click Here

Therapeutic Dose: Extending QbD to Stability Testing

The concept of a process signature can easily be extended to stability testing.

Click Here

Heparin Drama Underscores Need for More FDA Funding and Supplier Oversight

April brought painful reminders of the human cost of pharmaceutical quality control problems, the need for more FDA resources and better supplier risk management. It also highlighted the tenuous relationship that the Agency and its leaders already have with many U.S. lawmakers.

Click Here

Bridging the Gap

Despite talk of IT and process control convergence, the two functions are still disconnected, from each other and from manufacturing, at many pharmaceutical companies today.

Click Here

Grasping Lyophilization Product and Process Parameters for Biopharma

A clear understanding of product and process parameters is essential if freeze drying is not to remain a “trial and error” process. This excerpt from an authoritative book* summarizes the basics.

Click Here

PharmaView: Should Pharma Fear the Supply Chain of the Future?

As paradigms shift, we also need paradigm expansion.

Click Here

Real-Time Release: It’s Time for Action, Not Debate

Before arguing about Just in Time (JIT) solutions and how to define them, shouldn’t we look at why we need them, and form a plan?

Click Here

Pedigree Adopters Play the Waiting Game

Manufacturers’ electronic pedigree and serialization efforts creep ahead, slowed by FDA’s inaction.

Click Here

Building a Modeling Culture in Manufacturing at Pfizer

At Pfizer, the value of models is not in mimicking reality, but in illustrating the interactions between people, equipment, materials, and time.

Click Here

Light Induced Fluorescence as a “New” Tool for Pharmaceutical PAT

Light induced fluorescence can be considered a complementary tool in the pharmaceutical PAT toolbox.

Click Here

Monitoring Bioprocesses

The fermentation process is already fraught with risk. Monitoring offers an early warning system that can ensure batch-to-batch consistency and minimize waste.

Click Here

Webinar: PAT and Pharmaceutical Manufacturing: Overcoming the Trials and Tribulations

This webinar featuring Drs. Ian Mutton, PhD, formerly of Glaxo SmithKline, now Founder and Member IEXA100, Rick Cooley, PhD, formerly of Eli Lilly, now Market Development Manager Process Analytics, Dionex Corporation and Bruce Bailey, PhD Product Applications Manager, Dionex Corporation focuses on the challenges of PAT in moving on-line HPLC measurements from QC to process; and addresses the problems of non-UV absorbing analytes using Charged Aerosol Detection.

Click Here

Can Drug Manufacturers Find Business Benefits in Product Serialization?

John Danese, Oracle’s Director of Product Strategy, provides an update on the electronic pedigree landscape and how manufacturers are doing in their serialization efforts.

Click Here

Webcast: A Look Ahead: The Impact of Biosimilars on the Pharma Landscape

Follow-on biologics, or biosimilars, will soon become reality in the U.S. Given their inherent complexity and the current state of analytics, how will their safety and quality be ensured? Will they boost or diminish competition and innovation in biotech? Join us for a thought-provoking presentation and panel discussion of these issues.

Click Here

Webcast: Tech Transfer: Do We Have a Failure to Communicate?

Failure to transfer an analytical method or to move a process from lab to plant can cripple drug development efforts, wasting millions of dollars each year. Why do tech transfer projects fail? How can one ensure their success, whether one is transferring to another department or to a contract manufacturing organization? Join us for a controversial presentation and panel discussion of these issues.

Click Here

Webcast: Fix the Mix: Why Wyeth Turned to SAP Enterprise Inventory Optimization to Meet Supply Chain Targets

The pharmaceutical industry has not been shielded from the competitive dynamics of a "flat world." To remain ahead of their competitors, Wyeth Pharmaceuticals turned to Enterprise Inventory Optimization (EIO) to effectively manage inventory levels, service levels and costs. Join Allen Jacques, leader of Wyeth’s biopharma supply chain, and other speakers in this webcast to learn how Wyeth has leveraged SAP Enterprise Inventory Optimization by SmartOps.

Click Here

Funny Pharm: You Write the Caption & Win: January 2011

Introducing "Funny Pharm," sponsored by Paratherm Corp., featuring drawings by award-winning cartoonist Jerry King. Submit your caption and win.

Click Here

Webcast: An Off-the-Shelf SAP and E-Pedigree Solution for Small and Midsize Pharmaceutical Companies

This webcast, sponsored by IdhaSoft and SAP, will share information, ideas and case study experiences for improving operational efficiencies, reducing time to market and maintaining e-pedigree compliance.

Watch Now

LEAN and Six Sigma: Sustaining Gains Throughout the Product Lifecycle

In this webcast, companies that are in Lean Six Sigma for the long haul share best practices and the financial results that you can expect. They also address how to get management buy-in for programs that will withstand the test of time.

Click Here

Therapeutic Dose: Conservation of Natural Resources

OpEx and QbD, particularly the ideals of performance metrics and risk management, can be used to strengthen the relationship between partners in all pharmaceutical supply and contract situations. This webcast provides novel ideas and tangible suggestions for improving pharmaceutical partnerships. Speakers include: Russ Somma, PhD, president of SommaTech, LLC; Rakesh Kishan, president of UMS Advisory, Inc.; and Ron Perry, Co-Champion, Wyeth Supplier Quality Excellence Team.

Watch Now

Webcast: Biopharmaceutical Manufacturing Gears Up for 2020

As biopharmaceuticals development and manufacturing become more important, new challenges in up- and down-stream processing, manufacturing, analytics and process control must be met and overcome. This webcast focuses on key issues for the industry including manufacturing operations, analytics, process control and Lean and Six Sigma.

Watch Now

Webcast: Quality by Design and Product Purity: Breaking through Standard Method Validation with the Corona CAD Universal HPLC Detector

Watch this webcast to learn how a new universal HPLC detector, the Corona CAD, has been evaluated for the development of validated methods by several pharmaceutical and biotech companies. Details of the validation of methods will be presented for two sample sets: accurate measurements of a traditional small molecule drug substance, and impurity determinations of a peptide drug product formulated in a mixture of lipids and phospholipids. The Corona CAD methods were rigorously and successfully validated against standard method validation criteria. The data presented here demonstrate that not only can validated methods be developed using the Corona CAD, but that the Corona CAD enables previously difficult analyses, saving time and resources.

Watch Now

Webcast: Compliant Manufacturing: Enabling Superior Operations Performance in the Pharmaceutical Industry

Learn why operational excellence is mission critical to compliant manufacturing in this webcast by SAP.

Watch Now

Anticounterfeiting the Focus of USP Science Meeting

Raman, and What It Still Needs, Highlight Discussions

Watch Now

Webcast: Make Method Transfer and Validation Routine: from Ions to Small Molecules to Peptides

Implementation and validation of methods for the production environment can be a significant stumbling block. With QbD appearing on the scene there will be even greater pressure. Join us to learn how Synomics Pharmaceutical Services has implemented and validated methods using HPLC with charged aerosol detection for a wide range of analyses from counterions, to small molecules, to peptide pharmaceutical agents.The Corona detector has been widely adopted by the pharmaceutical industry. With its consistency of response that is independent of chemical structure, wide dynamic range and high sensitivity it is applicable to a wide array of analytes. Find out how it works and the secrets to ease of implementation.

Watch Now
Back to Top